Is there a benefit to adding rituximab to CHOP in the overall survival of patients with B-cell non-Hodgkin's lymphoma in a developing country?
Saved in:
| Title: | Is there a benefit to adding rituximab to CHOP in the overall survival of patients with B-cell non-Hodgkin's lymphoma in a developing country? |
|---|---|
| Authors: | Ruiz-Delgado GJ; Centro de Hematología y Medicina Interna, Clínica RUIZ, Puebla, Mexico. gruiz1@clinicaruiz.com, Gómez-Almaguer D, Tarín-Arzaga LC, Cantú-Rodriguez OG, Urdaneta CA, Rodríguez-Morales U, Calderón-Garcia J, Fernández-Vargas O, Montes-Montiel M, Sánchez-Cárdenas M, Ruiz-Argüelles GJ |
| Source: | Hematology (Amsterdam, Netherlands) [Hematology] 2012 Jul; Vol. 17 (4), pp. 193-7. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: England NLM ID: 9708388 Publication Model: Print Cited Medium: Internet ISSN: 1607-8454 (Electronic) Linking ISSN: 10245332 NLM ISO Abbreviation: Hematology Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1607-8454 |
|---|---|
| DOI: | 10.1179/1607845412Y.0000000006 |
